ROYALTY PHARMA PLC CLASS A (RPRX)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for RPRX
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| RPRX | Director | 63 | ["Chair, Department of Molecular Biology at Princeton University","Professor in the Department of Molecular Biology since 1994","Associated faculty member of the Department of Chemistry since 2010","Investigator at the Howard Hughes Medical Institute since 2005","Associate faculty member of the Princeton Environmental Institute since 1996","Director of the Council on Science and Technology at Princeton University from July 2008 to June 2013","Trustee of the Alfred P. Sloan Foundation since 2014","Board member of the American Association for the Advancement of Science from January 2012 to December 2016","Member of the National Science Board from January 2010 until May 2016","Elected to the National Academy of Sciences, the National Academy of Medicine, and the Royal Society"] | ["Management Development and Compensation Committee"] | 2026 |
Biography sourced from the proxy statement filing.
Dr. Bassler currently serves in several roles at Princeton University, including Professor in the Department of Molecular Biology since 1994, associated faculty member of the Department of Chemistry since 2010, Investigator at the Howard Hughes Medical Institute since 2005, and associate faculty member of the Princeton Environmental Institute since 1996. Previously, Dr. Bassler served as the Director of the Council on Science and Technology at Princeton University from July 2008 to June 2013. Dr. Bassler has served as a Trustee of the Alfred P. Sloan Foundation since 2014. Dr. Bassler served as a board member of the American Association for the Advancement of Science from January 2012 to December 2016. She was a member of the National Science Board from January 2010 until May 2016. Dr. Bassler has been elected to the National Academy of Sciences, the National Academy of Medicine, and the Royal Society, among other honorific organizations. She received a B.S. in biochemistry from the University of California-Davis and a Ph.D. in biochemistry from the John Hopkins University. Other Public Company Directorships: Regeneron Pharmaceuticals, Inc. (2016-present) Former Other Public Company Directorships : Cidara Therapeutics, Inc. (2021-2026) Kaleido Biosciences, Inc. (2018-2022) Qualifications: Dr. Bassler was selected to serve on our Board because of her extensive scientific knowledge and her scientific and academic career and accomplishments. Dr. Bassler s experience serving on boards across academia and the biopharmaceutical industry provides her with important qualifications and skills to serve on our Board.